Advertisement

PentaVision

Retinal Physician

Article | 2026 Clinical Trials at the Summit

A Potential First Treatment for Stargardt Disease

Data from the phase 3 DRAGON trial support tinlarebant as a treatment for the inherited retinal disorder. Belite Bio has completed a rolling NDA submission to the FDA.

By: Quan Dong Nguyen, MD, Diana V. Do, MD
Retinal Physician June 23, 2026
Top Institutions in Ophthalmology

Ranking is based on citation frequency across our internal corpus of peer-reviewed articles.

  • #1

    Stanford University
    Stanford University

    Stanford, CA

    Stanford University has a strong presence in ophthalmology research, particularly in the context of Stargardt disease.

    Key Differentiators

    • Ophthalmology

  • #2

    Retina Consultants of Texas
    Retina Consultants of Texas

    Dallas, TX

    Retina Consultants of Texas has contributed valuable patient data to the ongoing research on Stargardt disease.

    Key Differentiators

    • Ophthalmology

  • #3

    Casey Eye Institute of the Oregon Health & Science University
    Casey Eye Institute of the Oregon Health & Science University

    Portland, OR

    Casey Eye Institute is involved in significant research efforts in the field of retinal diseases.

    Key Differentiators

    • Ophthalmology

  • #4

    Institute of Molecular and Clinical Ophthalmology Basel
    Institute of Molecular and Clinical Ophthalmology Basel

    Basel, Switzerland

    The institute is recognized for its innovative gene editing therapies aimed at treating retinal diseases.

    Key Differentiators

    • Ophthalmology

  • #5

    University of California, Irvine School of Medicine
    University of California, Irvine School of Medicine

    Irvine, CA

    The university's department of ophthalmology is actively engaged in research on various retinal conditions.

    Key Differentiators

    • Ophthalmology